Medtronic Xomed, Inc. recalls NIM TRIVANTAGE EMG Endotracheal Tube

Recalled March 16, 2022 · FDA recall Z-0743-2022 · Medtronic Xomed

Hazard

There is potential for multiple issues due to a manufacturing nonconformity. · FDA Class II

Units

301,926 devices

Sold at

Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Canada, Canary Islands, Chile, China, Colombia, Costa Rica, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Faroe Islands, Finland, France, French Guinea, Germany, Greece, Guadeloupe, Guam, Guatemala, Hong Kong, Hungary, Iceland, India, Ireland, Israel, Italy, Japan, Korea (Republic of), Kuwait, Lebanon, Libya, Luxembourg, Malaysia, Mauritius, Mayotte, Mexico, Morocco, Namibia, Netherlands, New Caledonia, New Zealand, North Macedonia, Norway, Panama, Philippines, Poland, Portugal, Qatar, Reunion, Romania, Russia, Saudi Arabia, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Arab Emirates, United Kingdom, and Vietnam.

Description

There is potential for multiple issues due to a manufacturing nonconformity.

Product

NIM TRIVANTAGE EMG Endotracheal Tube

Manufacturer(s)

Medtronic Xomed, Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →